NCT01670539 arm group d3e2969fd0ee346d4b3704fa8907589e [clinicaltrials_resource:NCT01670539/arm-group/d3e2969fd0ee346d4b3704fa8907589e]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01670539 arm group d3e2969fd0ee346d4b3704fa8907589e [clinicaltrials_resource:NCT01670539/arm-group/d3e2969fd0ee346d4b3704fa8907589e]
Bio2RDF identifier
NCT01670539/arm-group/d3e2969fd0ee346d4b3704fa8907589e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... e2969fd0ee346d4b3704fa8907589e
description [clinicaltrials_vocabulary:description]
In addition to routine care, t ...... monitor outcomes for 2 months.
identifier
clinicaltrials_resource:NCT01670539/arm-group/d3e2969fd0ee346d4b3704fa8907589e
title
NCT01670539 arm group d3e2969fd0ee346d4b3704fa8907589e
@en
type
label
NCT01670539 arm group d3e2969f ...... 2969fd0ee346d4b3704fa8907589e]
@en